The risk of febrile neutropenia and need for G-CSF primary prophylaxis with the docetaxel and cyclophosphamide regimen in early-stage breast cancer patients: a meta-analysis

Breast Cancer Research and Treatment
Tran DoMeghana V Trivedi

Abstract

The febrile neutropenia (FN) rates reported with the docetaxel 75 mg/m(2) plus cyclophosphamide 600 mg/m(2) (TC) regimen given every 3 weeks vary from 4 to 69 % in early-stage breast cancer (ESBC) patients. This creates uncertainty as to whether patients receiving the TC regimen should also receive granulocyte colony-stimulating factor primary prophylaxis (G-CSFpp), which is recommended when chemotherapy regimens have ≥20 % FN rate. We conducted a meta-analysis of published studies to determine FN rate with the TC regimen, its dependence on patients' age, and the efficacy of G-CSFpp in reducing it in ESBC patients. We systematically searched the literature via PUBMED using the following terms: 'docetaxel', 'cyclophosphamide', 'febrile neutropenia', and 'breast cancer'. Inclusion criteria were full text peer-reviewed clinical studies in English reporting FN rates with TC regimen in relationship to G-CSFpp. Comprehensive meta-analysis software was used for all statistical analyses. Eight studies (N = 1542 patients) were included in our meta-analysis. The pooled mean FN rate was 23.2 % (95 % confidence interval (CI) 6.9-55.2 %; Q = 218.17, I (2) = 97.7). The FN risk in <65 years old patients was lower by 67.7 % compared to that in...Continue Reading

References

Jun 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L W KwakS J Horning
Feb 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L VogelLee S Schwartzberg
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S E JonesP M Ravdin
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J SmithAntonio C Wolff
Feb 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Linda S EltingKenneth Rolston
Mar 21, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ruth PettengellUNKNOWN Impact of Neutropenia in Chemotherapy-European Study Group (INC-EU)
Jun 17, 2008·American Journal of Public Health·Jesse A BerlinSusan S Ellenberg
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen JonesMichael A Savin
Jun 6, 2009·Japanese Journal of Clinical Oncology·Daisuke TakabatakeShigemitu Takashima
Jul 23, 2009·BMJ : British Medical Journal·David MoherUNKNOWN PRISMA Group
Mar 17, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Alexandre ChanRaymond Ng
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J CrawfordUNKNOWN ESMO Guidelines Working Group
Nov 26, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M S AaproUNKNOWN European Organisation for Research and Treatment of Cancer
May 14, 2011·Critical Reviews in Oncology/hematology·Gilles FreyerClaire Falandry
Sep 16, 2011·Expert Review of Anticancer Therapy·Marco DanovaGiovanni L Pappagallo
Jan 13, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Yoshimasa KosakaKazuo Tamura

❮ Previous
Next ❯

Citations

Aug 14, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Florence Van RyckeghemSimon Van Belle
Jun 29, 2017·Cancer Chemotherapy and Pharmacology·Ida NetterbergMats O Karlsson
Feb 26, 2021·The Breast : Official Journal of the European Society of Mastology·Takashi IshikawaUNKNOWN for Comprehensive Support Project for Oncological Research of Breast Cancer
Aug 4, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Jamal ZekriAhmed Allithy
Sep 18, 2021·Breast Cancer Research and Treatment·Hannah Van BelleHans Wildiers

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Related Papers

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Hazem AssiDaniel Rayson
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Alexandre ChanRaymond Ng
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Tallal YounisKara Thompson
© 2021 Meta ULC. All rights reserved